intramuscularly or minute until the desired subcutaneously. Additional response is obtained. doses should be based on Paediatric dose: The patient response. The recommended paediatric intravenous route may be dose is 3 mg/kg/day or used if an immediate 100 mg/m2/day via the response is required. The intravenous route, given in dosage for the intravenous 4 to 6 divided doses. route is 10 to 25 mg which may be repeated every 5 to During therapy with a 10 minute until the desired pressor agent, blood response is obtained. pressure should be elevated to slightly less Paediatric dose: The than the patient’s normal recommended paediatric blood pressure. In dose is 3 mg/kg/day or previously normotensive 100 mg/m2/day via the patients, systolic blood intravenous or pressure should be subcutaneous route, given maintained at 80 to 100 in 4 to 6 divided doses. mmHg. In previously During therapy with a hypertensive patients, pressor agent, blood systolic blood pressure pressure should be should be maintained at 30 elevated to slightly less to 40 mmHg below their than the patient’s normal usual blood pressure. In blood pressure. In some patients with very previously normotensive severe hypotension, patients, systolic blood maintenance of even lower pressure should be blood pressure may be maintained at 80 to 100 desirable if blood or fluid mmHg. In previously volume replacement has hypertensive patients, not been completed. systolic blood pressure should be maintained at 30 to 40 mmHg below their usual blood pressure. In some patients with very severe hypotension, maintenance of even lower blood pressure may be desirable if blood or fluid volume replacement has not been completed. Bronchospasm: dose: The usual adult dose is 12.5 to 25 mg, given intramuscularly, subcutaneously or intravenously. Further dosage should be determined by patient’s response. Paediatric dose: The usual paediatric dose is 3 mg/kg/day or 100 mg/m2/day via the intravenous or
intramuscularly or subcutaneously. Additional doses should be based on patient response. The intravenous route may be used if an immediate response is required. The dosage for the intravenous route is 10 to 25 mg which may be repeated every 5 to 10 minute until the desired response is obtained. Paediatric dose: The recommended paediatric dose is 3 mg/kg/day or 100 mg/m2/day via the intravenous or subcutaneous route, given in 4 to 6 divided doses. During therapy with a pressor agent, blood pressure should be elevated to slightly less than the patient’s normal blood pressure. In previously normotensive patients, systolic blood pressure should be maintained at 80 to 100 mmHg. In previously hypertensive patients, systolic blood pressure should be maintained at 30 to 40 mmHg below their usual blood pressure. In some patients with very severe hypotension, maintenance of even lower blood pressure may be desirable if blood or fluid volume replacement has not been completed. Bronchospasm: dose: The usual adult dose is 12.5 to 25 mg, given intramuscularly, subcutaneously or intravenously. Further dosage should be determined by patient’s response. Paediatric dose: The usual paediatric dose is 3 mg/kg/day or 100 mg/m2/day via the intravenous or minute until the desired response is obtained. Paediatric dose: The recommended paediatric dose is 3 mg/kg/day or 100 mg/m2/day via the intravenous route, given in 4 to 6 divided doses. During therapy with a pressor agent, blood pressure should be elevated to slightly less than the patient’s normal blood pressure. In previously normotensive patients, systolic blood pressure should be maintained at 80 to 100 mmHg. In previously hypertensive patients, systolic blood pressure should be maintained at 30 to 40 mmHg below their usual blood pressure. In some patients with very severe hypotension, maintenance of even lower blood pressure may be desirable if blood or fluid volume replacement has not been completed.
auspar-ephedrine-hydrochloride-171013.docx